| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3295362 | Gastroenterology | 2009 | 13 Pages |
Abstract
Sexual impairment is common among men with chronic hepatitis C undergoing therapy with pegylated interferon and ribavirin and should be considered as a potential side effect of antiviral therapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Lorna M. Dove, Raymond C. Rosen, Darmendra Ramcharran, Abdus S. Wahed, Steven H. Belle, Robert S. Brown, Jay H. Hoofnagle, Virahep-C Study Group Virahep-C Study Group,